Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors

Abstract

The present invention concerns the compounds having the formula N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein Rand Reach are H, optionally substituted Calkyl, Calkenyl, Ccycloalkyl, aryl, Het, Het; Rmay also be a radical of formula (RR)NC(RR)CR—; t is 0, 1 or 2; Ris H or Calkyl; L is —C(═O)—, —O—C(═O)—, —NR—C(═O)—, —O—Calkanediyl-C(═O)—, —NR—Calkanediyl-C(═O)—, —S(═O)—, —O—S(═O)—, —NR—S(═O); Ris Calkyl, aryl, Ccycloalkyl, CcycloalkylCalkyl, or arylCalkyl; Ris H, CalkylOC(═O), carboxyl, aminoC(═O), mono- or di(Calkyl)aminoC(═O), Ccycloalkyl, Calkenyl, Calkynyl or optionally substituted Calkyl; Rand Rare H or Calkyl. It further relates to their use as broadspectrum HIV protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. It also concerns combinations thereof with another anti-retroviral agent, and to their use in assays as reference compounds or as reagents.